Product Program year 2019 Source: CMS Open Payments

Gardasil9

Biological Vaccine

NDC 0006-4119-01

Open in the dashboard

General payments

$647,371

35,966 payments

Research payments

$441,779

111 payments

Through program year 2019, $647,371 in general payments and $441,779 in research payments were reported against Gardasil9 (Vaccine).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $647,371 35,966
2019 Research $441,779 111

Breakdown

Who paid General payments · program year 2019
  1. Merck Sharp & Dohme Corporation $647,371 35,966 payments
Top recipients General payments · program year 2019
  1. Mark Stoler Anatomic Pathology · Charlottesville, VA $34,539 5% · 6 payments
  2. Brigitte Ronnett Anatomic Pathology & Clinical Pathology · Baltimore, MD $20,040 3% · 8 payments
  3. Daron Ferris Family Medicine · Augusta, GA $17,689 3% · 2 payments
  4. Robert Kurman Anatomic Pathology & Clinical Pathology · Baltimore, MD $12,692 2% · 3 payments
  5. Ohsu Hospital And Clinics Teaching hospital · OR $4,200 <1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Family Medicine $144,927 25% · 6,223 practitioners
  2. Obstetrics & Gynecology $134,715 23% · 5,298 practitioners
  3. Pediatrics $127,025 22% · 6,274 practitioners
  4. Internal Medicine $67,294 12% · 3,243 practitioners
  5. Anatomic Pathology Pathology $34,539 6% · 1 practitioner

The top 5 of 106 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $57,942 9% · 2,473 recipients
  2. Virginia $54,943 8% · 780 recipients
  3. Texas $51,422 8% · 2,199 recipients
  4. Maryland $47,138 7% · 679 recipients
  5. Florida $35,676 6% · 1,684 recipients

The top 5 of 55 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

6,188

Prescriptions dispensed, refills included

Drug cost

$1,673,759

Paid at the pharmacy, in all

Prescribers

81

With 11 or more claims of it

Medicare Part D drugs matched to GARDASIL9, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Gardasil 9 Hpv Vaccine 9-Valent/Pf Same name 81 6,188 $1,673,759

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 81 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Armaghan Azad Emergency Medicine CA 660 $194,675 None on record
Cedric Davis Family Practice IL 622 $153,654 None on record
Alejandra Moscoso Family Practice TX 282 $67,560 None on record
Ruth Mays Family Practice MI 263 $74,673 None on record
Eldridge Burns Family Practice NE 257 $65,557 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 81 with Patron
35,966 general · 111 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record